2M7C.F
China Medical System Holdings Limited
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
1.23
▼ 0.07 (5.38%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
1.30
Day high
1.23
Day low
1.23
Volume
67
Market cap
$2.99B
P/E (TTM)
15.38
52W range
1.09 – 1.65
Trailing performance
Returnvs SPY
1W
-3.15%
-1.8%
1M
-7.52%
-11.2%
3M
+5.13%
+2.0%
6M
-24.07%
-35.1%
YTD
-12.14%
-24.4%
1Y
-15.75%
-35.8%
3Y
-4.65%
-78.8%
5Y
-22.64%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 2M7C.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.17B
Total on file
Fundamentals
Market cap$2.99B
Enterprise value$-1.59B
Revenue (TTM)$8.71B
Gross profit$6.20B
EBITDA$2.00B
Net income$1.53B
EPS (TTM)$0.08
Free cash flow—
Total cash$5.75B
Total debt$882.94M
Book value / share$0.94
Shares outstanding2.43B
Float1.24B
Short % of float—
Dividend yield2.90%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E15.38
Forward P/E—
PEG ratio—
Price / sales—
Price / book1.30
EV / revenue-0.18
EV / EBITDA-0.80
Gross margin71.18%
Operating margin22.06%
Profit margin17.61%
Return on equity8.42%
Return on assets5.62%
Debt / equity4.88
Current ratio6.64
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.21B | $7.47B | $8.01B | $9.15B | +9.9% |
| Operating revenue | $8.21B | $7.47B | $8.01B | $9.15B | +9.9% |
| Cost of revenue | $2.34B | $2.05B | $1.90B | $2.11B | +14.4% |
| Gross profit | $5.87B | $5.42B | $6.11B | $7.04B | +8.3% |
| Research & development | $585.02M | $329.98M | $195.13M | $125.43M | +77.3% |
| Selling, general & admin | $3.71B | $3.44B | $3.17B | $3.36B | +7.7% |
| Total operating expense | $4.23B | $3.69B | $3.28B | $3.39B | +14.6% |
| Operating income | $1.64B | $1.73B | $2.83B | $3.65B | -5.2% |
| Net interest income | $62.05M | $87.73M | $100.22M | $56.43M | -29.3% |
| Pre-tax income | $2.10B | $2.01B | $2.87B | $3.76B | +4.6% |
| Tax provision | $659.78M | $397.23M | $489.34M | $486.65M | +66.1% |
| Net income | $1.49B | $1.62B | $2.40B | $3.26B | -8.1% |
| Net income to common | $1.49B | $1.62B | $2.40B | $3.26B | -8.1% |
| Basic EPS | 0.62 | 0.67 | 0.98 | 1.33 | -7.8% |
| Diluted EPS | 0.62 | 0.67 | 0.98 | 1.33 | -7.8% |
| EBIT | $2.12B | $2.05B | $2.92B | $3.81B | +3.6% |
| EBITDA | $2.39B | $2.31B | $3.15B | $4.04B | +3.6% |
| Basic shares | 2.42B | 2.43B | 2.45B | 2.45B | -0.3% |
| Diluted shares | 2.42B | 2.43B | 2.45B | 2.45B | -0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.70B | $3.71B | $4.31B | $4.38B | — | -27.1% |
| Cash & short-term investments | $5.79B | $5.87B | $6.14B | $5.87B | — | -1.4% |
| Accounts receivable | $1.59B | $1.22B | $1.15B | $1.44B | — | +29.9% |
| Inventory | $803.96M | $768.14M | $637.64M | $477.21M | — | +4.7% |
| Total current assets | $9.30B | $8.70B | $8.79B | $8.83B | — | +6.8% |
| Property, plant & equipment | $446.09M | $448.09M | $473.74M | $495.46M | — | -0.4% |
| Goodwill & intangibles | $5.21B | $5.04B | $4.78B | $5.02B | — | +3.3% |
| Total assets | $19.20B | $18.05B | $17.73B | $17.75B | — | +6.4% |
| Total current liabilities | $1.47B | $1.52B | $2.05B | $2.88B | — | -3.1% |
| Current debt | $651.82M | $831.30M | $1.27B | $1.78B | — | -21.6% |
| Long-term debt | — | — | — | $0 | $573.81M | — |
| Total debt | $690.08M | $860.74M | $1.30B | $1.81B | — | -19.8% |
| Total liabilities | $1.66B | $1.64B | $2.17B | $3.02B | — | +0.7% |
| Retained earnings | $14.74B | $13.96B | $13.00B | $11.53B | — | +5.6% |
| Shareholder equity | $17.40B | $16.31B | $15.52B | $14.59B | — | +6.6% |
| Working capital | $7.83B | $7.19B | $6.75B | $5.95B | — | +8.9% |
| Net tangible assets | $12.19B | $11.27B | $10.74B | $9.57B | — | +8.1% |
| Shares issued | 2.44B | 2.44B | 2.45B | 2.45B | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.10B | $2.01B | $2.87B | $3.76B | +4.6% |
| Depreciation & amortisation | $266.93M | $259.24M | $229.56M | $227.23M | +3.0% |
| Stock-based compensation | $27.31M | $0 | -$35.87M | $18.72M | — |
| Change in working capital | -$648.78M | -$128.15M | $2.97M | $90.08M | -406.3% |
| Operating cash flow | $758.42M | $1.27B | $2.50B | $3.55B | -40.2% |
| Capital expenditure | -$514.41M | -$455.91M | -$317.96M | -$524.92M | -12.8% |
| Investing cash flow | -$984.32M | -$615.10M | -$442.28M | -$1.18B | -60.0% |
| Share buybacks | $0 | -$238.39M | $0 | -$48.38M | +100.0% |
| Dividends paid | -$660.55M | -$556.16M | -$1.36B | -$1.28B | -18.8% |
| Financing cash flow | -$770.94M | -$1.26B | -$2.13B | -$1.40B | +38.9% |
| Free cash flow | $244.01M | $812.64M | $2.18B | $3.03B | -70.0% |
| End cash position | $2.70B | $3.71B | $4.31B | $4.38B | -27.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $2.70B | $3.45B | $3.71B | -21.8% |
| Cash & short-term investments | $5.79B | $5.97B | $5.87B | -3.0% |
| Accounts receivable | $1.59B | $1.92B | $1.22B | -17.2% |
| Inventory | $803.96M | $791.99M | $768.14M | +1.5% |
| Total current assets | $9.30B | $9.29B | $8.70B | +0.1% |
| Property, plant & equipment | $446.09M | $435.58M | $448.09M | +2.4% |
| Goodwill & intangibles | $5.21B | $5.19B | $5.04B | +0.4% |
| Total assets | $19.20B | $18.94B | $18.05B | +1.4% |
| Total current liabilities | $1.47B | $1.61B | $1.52B | -8.6% |
| Current debt | $651.82M | $715.00M | $831.30M | -8.8% |
| Total debt | $690.08M | $747.60M | $860.74M | -7.7% |
| Total liabilities | $1.66B | $1.77B | $1.64B | -6.5% |
| Retained earnings | $14.74B | — | $13.96B | — |
| Shareholder equity | $17.40B | $17.02B | $16.31B | +2.2% |
| Working capital | $7.83B | $7.68B | $7.19B | +1.9% |
| Net tangible assets | $12.19B | $11.83B | $11.27B | +3.0% |
| Shares issued | 2.44B | — | 2.44B | — |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $9.61B | +17.0% |
| Next year | — | — | $11.56B | +20.3% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders48.28%
Held by institutions26.30%
Institutions holding134
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.27
-3.38% from price
SMA 20
1.29
-4.76% from price
SMA 50
1.27
-2.94% from price
SMA 100
1.29
-4.35% from price
SMA 200
1.38
-11.18% from price
EMA 12
1.28
-3.64% from price
EMA 26
1.29
-4.29% from price
EMA 50
1.28
-4.09% from price
RSI (14)
40.1
Neutral
MACD (12,26,9)
-0.01
Hist -0.01
ATR (14)
0.03
2.56% of price
Realised vol 30D
33.5%
Annualised
Bollinger upper
1.34
20, 2σ
Bollinger lower
1.24
20, 2σ
50 / 200 cross
Death
1.27 vs 1.38
Trend bias
Below 200
-11.18%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.14
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
33.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-33.9%
Peak to trough
Max drawdown 5Y
-61.0%
Peak to trough
ATR 14
0.03
2.56% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate$0.04 / yr
Forward yield2.90%
5-year avg yield4.33%
Payout ratio45.95%
Ex-dividend dateAug 28, 2026
Next pay date—
Last split3:2
Split dateApr 27, 2012
Headlines
Net Asset Value(s)
Business Wire · 6m ago
Tea and Coffee Packaging Machinery Market Outlook 2026-2035 Featuring Strategic Profiles of IMA Group, Syntegon Technology, Coesia Group, GEA Group, Tetra Pak and Regional Powerhouses
GlobeNewswire · 9m ago
Low Carbon wins DCO for Beacon Fen Energy Park in Lincolnshire
Power Technology · 9m ago
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
StockStory · 10m ago
Market Chatter: Citigroup Working With Axis Bank to Finance NRI Foreign-Currency Deposits
MT Newswires · 11m ago
Alibaba Prices Hong Kong Equity Placement; Shares Down Pre-Bell
MT Newswires · 11m ago
Samsung Falls 8.7% After Record $79 Billion Payout Disappoints
BeInCrypto · 13m ago
Morgan Stanley starts Rio Tinto ADR coverage at underweight, sees 14% downside
Investing.com · 13m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.